Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - PETMED EXPRESS INC | pets012411_8k.htm |
Exhibit 99.1
PETMED EXPRESS D/B/A 1-800-PETMEDS
ANNOUNCES ITS THIRD QUARTER FINANCIAL RESULTS
Pompano Beach, Florida, January 24, 2011 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended December 31, 2010. Net sales for the quarter ended December 31, 2010 were $45.1 million, compared to $48.4 million for the quarter ended December 31, 2009, a decrease of 6.7%. Net sales for the nine months ended December 31, 2010 were $180.7 million, compared to $188.0 million for the nine months ended December 31, 2009, a decrease of 3.9%. Net income was $4.5 million, or $0.20 diluted per share, for the quarter ended December 31, 2010, compared to net income of $5.6 million, or $0.25 diluted per share, for the quarter ended December 31, 2009, a 19% decrease to EPS. Net income was $16.7 million, or $0.74 diluted per share, for the nine months ended December 31, 2010, compared to net income of $19.9 million, or $0.88 diluted per share, for the nine months ended December 31, 2009, a 16% decrease to EPS.
Menderes Akdag, President and CEO, commented: “It has been another challenging quarter, due to reduced advertising as a result of tighter television advertising inventory combined with consumers giving greater consideration to price and a softer demand for some of the product categories we offer. Going forward we intend to implement a more aggressive pricing strategy combined with increased advertising, while continuing to expand our product offerings into pet supplies. During the quarter we bought back approximately 66,000 shares of our common stock for $1.0 million, and so far in January we have bought back approximately 101,000 shares of our common stock for $1.6 million. During the quarter we also paid our quarterly dividend of $0.125 per share, an increase of 25% from the prior year. Our cash flows from operations increased to $31.5 million for the nine months ended December 31, 2010 from $28.9 million for the same period the prior year. “
This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter’s financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (210) 234-0009. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on January 24, 2011 until February 7, 2011 at 11:59 P.M. To access the replay, call (800) 731-6039 (toll free) or (203) 369-3823, and enter passcode 5500.
Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.
This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2010. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.
For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.
###
Exhibit 99.1 Page 1 of 4
PETMED EXPRESS, INC. AND SUBSIDIARIES | ||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||
(In thousands) | ||||
|
| December 31, |
| March 31, |
|
| 2010 |
| 2010 |
|
| (Unaudited) |
|
|
ASSETS |
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
Cash and cash equivalents | $ | 61,254 | $ | 53,143 |
Short term investments - available for sale |
| 10,077 |
| - |
Accounts receivable, less allowance for doubtful |
|
|
|
|
accounts of $2 and $5, respectively |
| 802 |
| 2,097 |
Inventories - finished goods |
| 14,885 |
| 29,064 |
Prepaid expenses and other current assets |
| 1,848 |
| 610 |
Deferred tax assets |
| 1,543 |
| 1,255 |
Prepaid income taxes |
| 871 |
| 330 |
Total current assets |
| 91,280 |
| 86,499 |
|
|
|
|
|
Long term investments |
| 12,381 |
| 12,392 |
Property and equipment, net |
| 3,739 |
| 4,429 |
Intangible asset |
| 860 |
| 850 |
|
|
|
|
|
Total assets | $ | 108,260 | $ | 104,170 |
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
Accounts payable | $ | 3,085 | $ | 4,776 |
Accrued expenses and other current liabilities |
| 2,144 |
| 2,312 |
Total current liabilities |
| 5,229 |
| 7,088 |
|
|
|
|
|
Deferred tax liabilities |
| 715 |
| 225 |
|
|
|
|
|
Total liabilities: |
| 5,944 |
| 7,313 |
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
Preferred stock, $.001 par value, 5,000 shares authorized; |
|
|
|
|
3 convertible shares issued and outstanding with a |
|
|
|
|
liquidation preference of $4 per share |
| 9 |
| 9 |
Common stock, $.001 par value, 40,000 shares authorized; |
|
|
|
|
22,783 and 22,990 shares issued and outstanding, respectively |
| 23 |
| 23 |
Additional paid-in capital |
| - |
| 2,628 |
Retained earnings |
| 102,431 |
| 94,305 |
Accumulated other comprehensive loss |
| (147) |
| (108) |
|
|
|
|
|
Total shareholders' equity |
| 102,316 |
| 96,857 |
|
|
|
|
|
Total liabilities and shareholders' equity | $ | 108,260 | $ | 104,170 |
Exhibit 99.1 Page 2 of 4
PETMED EXPRESS, INC. AND SUBSIDIARIES | ||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||||
(In thousands, except for per share amounts)(Unaudited) | ||||||||
|
|
|
|
|
|
|
|
|
|
| Three Months Ended |
| Nine Months Ended | ||||
|
| December 31, |
| December 31, | ||||
|
| 2010 |
| 2009 |
| 2010 |
| 2009 |
|
|
|
|
|
|
|
|
|
Sales | $ | 45,118 | $ | 48,353 | $ | 180,732 | $ | 187,969 |
Cost of sales |
| 28,193 |
| 29,525 |
| 114,251 |
| 116,173 |
|
|
|
|
|
|
|
|
|
Gross profit |
| 16,925 |
| 18,828 |
| 66,481 |
| 71,796 |
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
General and administrative |
| 5,096 |
| 4,929 |
| 17,017 |
| 17,199 |
Advertising |
| 4,444 |
| 5,177 |
| 21,859 |
| 22,801 |
Depreciation and amortization |
| 358 |
| 337 |
| 1,023 |
| 982 |
Total operating expenses |
| 9,898 |
| 10,443 |
| 39,899 |
| 40,982 |
|
|
|
|
|
|
|
|
|
Income from operations |
| 7,027 |
| 8,385 |
| 26,582 |
| 30,814 |
|
|
|
|
|
|
|
|
|
Other income (expense): |
|
|
|
|
|
|
|
|
Interest income, net |
| 98 |
| 46 |
| 265 |
| 165 |
Other, net |
| (144) |
| 1 |
| (111) |
| 4 |
Total other income (expense) |
| (46) |
| 47 |
| 154 |
| 169 |
|
|
|
|
|
|
|
|
|
Income before provision for income taxes |
| 6,981 |
| 8,432 |
| 26,736 |
| 30,983 |
|
|
|
|
|
|
|
|
|
Provision for income taxes |
| 2,459 |
| 2,842 |
| 10,011 |
| 11,053 |
|
|
|
|
|
|
|
|
|
Net income | $ | 4,522 | $ | 5,590 | $ | 16,725 | $ | 19,930 |
|
|
|
|
|
|
|
|
|
Net income per common share: |
|
|
|
|
|
|
|
|
Basic | $ | 0.20 | $ | 0.25 | $ | 0.74 | $ | 0.88 |
Diluted | $ | 0.20 | $ | 0.25 | $ | 0.74 | $ | 0.88 |
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding: |
|
|
|
|
|
| ||
Basic |
| 22,506 |
| 22,649 |
| 22,614 |
| 22,596 |
Diluted |
| 22,655 |
| 22,790 |
| 22,755 |
| 22,742 |
|
|
|
|
|
|
|
|
|
Cash dividends declared per common share | $ | 0.125 | $ | 0.100 | $ | 0.350 | $ | 0.200 |
Exhibit 99.1 Page 3 of 4
PETMED EXPRESS, INC. AND SUBSIDIARIES | ||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||
(In thousands) (Unaudited) | ||||
|
| Nine Months Ended | ||
|
| December 31, | ||
|
| 2010 |
| 2009 |
Cash flows from operating activities: |
|
|
|
|
Net income | $ | 16,725 | $ | 19,930 |
Adjustments to reconcile net income to net cash |
|
|
|
|
provided by operating activities: |
|
|
|
|
Depreciation and amortization |
| 1,023 |
| 982 |
Share based compensation |
| 1,606 |
| 1,158 |
Deferred income taxes |
| 202 |
| 118 |
Bad debt expense |
| 30 |
| 29 |
(Increase) decrease in operating assets |
|
|
|
|
and increase (decrease) in liabilities: |
|
|
|
|
Accounts receivable |
| 1,265 |
| 1,670 |
Inventories - finished goods |
| 14,179 |
| 7,753 |
Prepaid income taxes |
| (541) |
| (1,440) |
Prepaid expenses and other current assets |
| (1,238) |
| (31) |
Accounts payable |
| (1,532) |
| (1,055) |
Accrued expenses and other current liabilities |
| (246) |
| (206) |
Net cash provided by operating activities |
| 31,473 |
| 28,908 |
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
Net change in investments |
| (10,104) |
| 2,150 |
Purchases of property and equipment |
| (491) |
| (853) |
Purchases of intangible asset |
| (10) |
| - |
Net cash (used in) provided by investing activities |
| (10,605) |
| 1,297 |
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
Dividends paid |
| (7,933) |
| (4,529) |
Purchases of treasury stock |
| (5,225) |
| - |
Proceeds from the exercise of stock options |
| 252 |
| 574 |
Tax benefit related to stock options exercised |
| 124 |
| 226 |
Deferred tax adjustment related to restricted stock |
| 25 |
| - |
Net cash used in financing activities |
| (12,757) |
| (3,729) |
|
|
|
|
|
Net increase in cash and cash equivalents |
| 8,111 |
| 26,476 |
Cash and cash equivalents, at beginning of period |
| 53,143 |
| 30,126 |
|
|
|
|
|
Cash and cash equivalents, at end of period | $ | 61,254 | $ | 56,602 |
|
|
|
|
|
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
|
|
|
Cash paid for income taxes | $ | 10,254 | $ | 12,149 |
|
|
|
|
|
Property and equipment purchases in accounts payable | $ | 259 | $ | 488 |
|
|
|
|
|
Dividends payable in accrued expenses | $ | 126 | $ | 38 |
Exhibit 99.1 Page 4 of 4